Incretin-based therapies boosting care, says endocrinologist
21st February 2016
UPDATED: 10am, 25 February, 2016.
Incretin-based therapies, with their very low side-effect profile, are significantly improving the management of type 2 diabetes, according to a leading endocrinologist.
Associate Professor Neale Cohen told delegates at Australian Doctor Education's Challenges in General Practice
